Latest Funding News

A1 Investments & Resources Limited reported negative operating cash flows and no business activity in Q1 2025, drawing down $200,000 of a $300,000 loan as it seeks a transaction to regain ASX listing status.

RareX Limited has won a $175,000 government-backed drilling grant to advance exploration of significant gallium mineralisation at its Khaleesi Project in Western Australia, underpinning the project’s critical minerals promise.

Dimerix has inked an exclusive US licensing agreement with Amicus Therapeutics for DMX-200, a promising Phase 3 treatment for FSGS, unlocking $30 million upfront and up to $560 million in milestones.

Assetora Limited has dramatically reduced its net liabilities and strengthened its balance sheet through strategic capital raises and debt conversions, while unveiling a comprehensive rebrand and leadership expansion to drive its next growth phase.

Australian Strategic Materials (ASM) outlines progress on its Korean Metals Plant ramp-up, strategic plans for a US metals facility, and conditional funding support for the Dubbo Project, reinforcing its mine-to-metals supply chain ambitions.

Baby Bunting Group unveils its ambitious ‘Store of the Future’ strategy, targeting a return to double-digit EBITDA margins through store refurbishments, new small format pilots, and enhanced omni-channel capabilities. The company sets FY25 NPAT guidance between $10 million and $12.5 million, underpinned by a 40% gross margin target.

Pilot Energy confirms regulatory compliance and operational progress at the Head Field, advancing the repurposing of Cliff Oil infrastructure into a carbon storage facility as part of the Mid West Clean Energy Project.

Eureka Group Holdings has upsized its debt facilities to $185 million with improved terms, enhancing its financial flexibility to expand residential developments across Australia.

Baby Bunting reports a 2.9% year-to-date comparable store sales growth and opens an innovative new store format in Melbourne, raising its FY25 NPAT guidance amid strong early results.

Anatara Lifesciences has obtained a $400,000 loan advance from a major shareholder group against its estimated R&D tax refund for the first half of FY2025, providing crucial funding to support ongoing clinical trials and product development without immediate capital raising.

Buxton Resources has won up to A$180,000 in government co-funding to kickstart drilling at its 100%-owned Madman Project in Western Australia, advancing exploration in a promising but underexplored gold-copper region.

Burgundy Diamond Mines reported a challenging Q1-2025 with lower ore mined and revenue, yet continues to progress development at Point Lake and Misery mines while strengthening its financial position.